Acute pancreatitis in two patients with Parkinson’s disease

References

• Adnet, P., Lestavel, P., & Krivosic-Horber, R. (2000). Neuroleptic malignant syndrome. British Journal of Anaesthesia, 85, 129–135.10.1093/bja/85.1.129
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos, G. K., Tsiakos, S., Margantinis, G., Kostopoulos, P., & Arvanitidis, D. (2003). Acute pancreatitis due to pravastatin therapy. JOP, 4, 129–132.
   PubMedGoogle Scholar
• Antonopoulos, S., Mikros, S., Kokkoris, S., Protopsaltis, J., Filioti, K., Karamanolis, D., & Giannoulis, G. (2005). A case of acute pancreatitis possibly associated with combined salicylate and simvastatin treatment. JOP, 6, 264–268.
   PubMedGoogle Scholar
• Badalov, N., Baradarian, R., Iswara, K., Li, J., Steinburg, W., & Tenner, S. (2007). Drug-induced acute pancreatitis: An evidence-based review. Clinical Gastroenterology and Hepatology, 5, 648–661.10.1016/j.cgh.2006.11.023
   PubMed Web of Science ®Google Scholar
• Barreto, S. G., Tiong, L., & Williams, R. (2011). Drug-induced acute pancreatitis in a cohort of 328 patients. A single-centre experience from Australia. JOP, 12, 581–585.
   PubMedGoogle Scholar
• Brennan, K. A., & Genever, R. W. (2010). Managing Parkinson’s disease during surgery. BMJ, 341, c5718.10.1136/bmj.c5718
   PubMed Web of Science ®Google Scholar
• Brooks, D. J. (2008). Optimizing levodopa therapy for Parkinson’s disease with levodopa/carbidopa/entacapone: Implications from a clinical and patient perspective. Neuropsychiatric Disease and Treatment, 4, 39–47.10.2147/NDT
   PubMedGoogle Scholar
• Case, R. M. (1998). Pancreatic exocrine secretion: Mechanisms and control. In H. G. Beger, A. W. Warshaw, & M. W. Buchler (Eds.), The pancreas (pp. 63–100). Oxford: Blackwell Science.
   Google Scholar
• Chawla, S., Atten, M. J., & Attar, B. M. (2011). Acute pancreatitis as a rare initial manifestation of Wegener’s granulomatosis. A case based review of literature. JOP, 12, 167–169.
   PubMedGoogle Scholar
• Chen, J. J., Swope, D. M., Dashtipour, K., & Lyons, K. E. (2009). Transdermal rotigotine: A clinically innovative dopamine-receptor agonist for the management of Parkinson’s disease. Pharmacotherapy, 29, 1452–1467.
   PubMed Web of Science ®Google Scholar
• Contin, M., Riva, R., Albani, F., & Baruzzi, A. (1996). Pharmacokinetic optimisation in the treatment of Parkinson’s disease. Clinical Pharmacokinetics, 30, 463–481.10.2165/00003088-199630060-00004
   PubMed Web of Science ®Google Scholar
• Duboeuf, T., De Widerspach-Thor, A., Scotto, B., & Bacq, Y. (2004). Acute glimepiride-induced pancreatitis. Gastroentérologie Clinique et Biologique, 28, 409–410.10.1016/S0399-8320(04)94947-0
   PubMedGoogle Scholar
• Eatock, F. C., Chong, P., Menezes, N., Murray, L., McKay, C. J., Carter, C. R., & Imrie, C. W. (2005). A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. The American Journal of Gastroenterology, 100, 432–439.10.1111/ajg.2005.100.issue-2
   PubMed Web of Science ®Google Scholar
• Eden, R. J., Costall, B., Domeney, A. M., Gerrard, P. A., Harvey, C. A., Kelly, M. E., ... Wright, A. (1991). Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist. Pharmacology Biochemistry and Behavior, 38, 147–154.10.1016/0091-3057(91)90603-Y
   PubMed Web of Science ®Google Scholar
• Eland, I. A., Sundström, A., Velo, G. P., Andersen, M., Sturkenboom, M. C., Langman, M. J., … For the EDIP Study Group of the European Pharmacovigilance Research Group. (2006). Antihypertensive medication and the risk of acute pancreatitis: The European case-control study on drug-induced acute pancreatitis (EDIP). Scandinavian Journal of Gastroenterology, 41, 1484–1490.10.1080/00365520600761676
   PubMed Web of Science ®Google Scholar
• Factor, S. A. (2007). Fatal Parkinsonism-hyperpyrexia syndrome in a Parkinson’s disease patient while actively treated with deep brain stimulation. Movement Disorders, 22, 148–149.10.1002/(ISSN)1531-8257
   PubMed Web of Science ®Google Scholar
• Famularo, G., Minisola, G., Nicotra, G. C., & De Simone, C. (2005). Diosyncratic pancreatitis associated with perindopril. JOP, 6, 605–607.
   PubMedGoogle Scholar
• Federico, E., Falconi, M., Zuodar, G., Falconieri, G., & Puglisi, F. (2011). B-cell lymphoma presenting as acute pancreatitis. Pancreatology, 11, 553–556.10.1159/000332038
   PubMed Web of Science ®Google Scholar
• Frossard, J. L., Steer, M. L., & Pastor, C. M. (2008). Acute pancreatitis. The Lancet, 371, 143–152.10.1016/S0140-6736(08)60107-5
   PubMed Web of Science ®Google Scholar
• Gerlach, O. H., Winogrodzka, A., & Weber, W. E. (2011). Clinical problems in the hospitalized Parkinson’s disease patient: Systematic review. Movement Disorders, 26, 197–208.
   PubMed Web of Science ®Google Scholar
• Gordon, P. H., & Frucht, S. J. (2001). Neuroleptic malignant syndrome in advanced Parkinson’s disease. Movement Disorders, 16, 960–962.10.1002/mds.v16:5
   PubMed Web of Science ®Google Scholar
• Harper, S. J., & Cheslyn-Curtis, S. (2011). Acute pancreatitis. Annals of Clinical Biochemistry, 48, 23–37.10.1258/acb.2010.010196
   PubMed Web of Science ®Google Scholar
• Iliopoulou, A., Giannakopoulos, G., Pagoy, H., Christos, T., & Theodore, S. (2001). Case report: Acute pancreatitis due to captopril treatment. Digestive Diseases and Sciences, 46, 1882–1883.10.1023/A:1010674812573
   PubMed Web of Science ®Google Scholar
• Johnson, J. L., & Loomis, I. B. (2006). A case of simvastatin-associated pancreatitis and review of statin-associated pancreatitis. Pharmacotherapy, 26, 414–422.10.1592/phco.26.3.414
   PubMed Web of Science ®Google Scholar
• Kaurich, T. (2008). Drug-induced acute pancreatitis. Proceedings of the Baylor University Medical Center, 21, 77–81.
   PubMedGoogle Scholar
• Khan, I. H., & Edward, N. (1993). Pancreatitis associated with diclofenac. Postgraduate Medical Journal, 69, 486–487.10.1136/pgmj.69.812.486
   PubMed Web of Science ®Google Scholar
• Kvemmo, T., Härtter, S., & Burger, E. (2006). A review of the receptor-binding and pharmacokinetic properties of dopamine agonists. Clinical Therapeutics, 28, 1065–1078.
   PubMed Web of Science ®Google Scholar
• Lankisch, P. G., Droge, M., & Gottesleben, F. (1995). Drug induced acute pancreatitis: Incidence and severity. Gut, 37, 565–567.10.1136/gut.37.4.565
   PubMed Web of Science ®Google Scholar
• LeWitt, P. A., Boroojerdi, B., & MacMahon, D. (2007). Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson’s disease. Clinical Neuropharmacology, 30, 256–265.10.1097/wnf.0b013e318154c7c4
   PubMed Web of Science ®Google Scholar
• Marik, P. E., & Zaloga, G. P. (2004). Meta-analysis of parenteral nutrition versus enteral nutrition in patients with acute pancreatitis. BMJ, 328, 1407–1412.10.1136/bmj.38118.593900.55
   PubMed Web of Science ®Google Scholar
• Miltiadous, G., Anthopoulou, A., & Elisaf, M. (2003). Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. JOP, 4, 20–21.
   PubMedGoogle Scholar
• Modena, J. T., Cevasco, L. B., Basto, C. A., Vicuna, A. O., & Ramirez, M. P. (2006). Total enteral nutrition as prophylactic therapy for pancreatic necrosis infection in severe acute pancreatitis. Pancreatology, 6, 58–64.10.1159/000090024
   PubMed Web of Science ®Google Scholar
• Muchnick, J. S., & Mehta, J. L. (1999). Angiotensin-converting enzyme inhibitor-induced pancreatitis. Clinical Cardiology, 22, 50–51.10.1002/clc.v22:1
   PubMed Web of Science ®Google Scholar
• Nashatizadeh, M. M., Lyons, K. E., & Pahwa, R. (2009). A review of ropinirole prolonged release in Parkinson’s disease. Clinical Interventions in Aging, 4, 179–186.
   PubMed Web of Science ®Google Scholar
• Newman, E. J., Grosset, D. G., & Kennedy, P. G. (2009). The Parkinsonism-hyperpyrexia syndrome. Neurocritical Care, 10, 136–140.10.1007/s12028-008-9125-4
   PubMed Web of Science ®Google Scholar
• Nitsche, C. J., Jamieson, N., Lerch, M. M., & Mayerle, J. V. (2010). Drug induced pancreatitis. Best Practice & Research Clinical Gastroenterology, 24, 143–155.10.1016/j.bpg.2010.02.002
   PubMed Web of Science ®Google Scholar
• Nutt, J. G., & Fellman, J. H. (1984). Pharmacokinetics of levodopa. Clin Neuropharmacol, 7, 35–39.
   PubMed Web of Science ®Google Scholar
• Onofrj, M., & Thomas, A. (2005). Acute akinesia in Parkinson disease. Neurology, 64, 1162–1169.10.1212/01.WNL.0000157058.17871.7B
   PubMed Web of Science ®Google Scholar
• Pahwa, R., Stacy, M. A., Factor, S. A., Lyons, K. E., Stocchi, F., Hersh, B. P., & EASE-PD Adjunct Study Investigators. (2007). Ropinirole 24-h prolonged release: Randomized, controlled study in advanced Parkinson disease. Neurology, 68, 1108–1115.10.1212/01.wnl.0000258660.74391.c1
   PubMed Web of Science ®Google Scholar
• Quinn, N., Marsden, C. D., & Parkes, J. D. (1982). Complicated response fluctuations in Parkinson’s disease: Response to intravenous infusion of levodopa. The Lancet, 320, 412–415.10.1016/S0140-6736(82)90442-1
   Google Scholar
• Ranson, J. H., Rifkind, K. M., Roses, D. F., Fink, S. D., Eng, K., & Spencer, F. C. (1974). Prognostic signs and the role of operative management in acute pancreatitis. Surgery, Gynecology & Obstetrics, 139, 69–81.
   PubMedGoogle Scholar
• Rosin, A. J., Devereux, D., Eng, N., Calne, D. B. (1979). Parkinsonism with ‘on-off’ phenomena. Intravenous treatment with levodopa after major abdominal surgery. Archives of Neurology, 36, 32–34.10.1001/archneur.1979.00500370062014
   PubMedGoogle Scholar
• Rünzi, M., & Layer, P. (1999). Nonsurgical management of acute pancreatitis: Use of antibiotics. Surgical Clinics of North America, 79, 759–765.
   PubMed Web of Science ®Google Scholar
• Schneider, L., Büchler, M. W., & Werner, J. (2010). Acute pancreatitis with an emphasis on infection. Infectious Disease Clinics of North America, 24, 921–941.
   PubMed Web of Science ®Google Scholar
• Sekimoto, M., Takada, T., Kawarada, Y., Hirata, K., Mayumi, T., Yoshida, M., ... Koizumi, S. (2006). JPN Guidelines for the management of acute pancreatitis: Epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. Journal of Hepato-Biliary-Pancreatic Surgery, 13, 10–24.10.1007/s00534-005-1047-3
   PubMedGoogle Scholar
• Serrano-Dueñas, M. (2003). Neuroleptic malignant syndrome-like, or – dopaminergic malignant syndrome – to levodopa therapy withdrawal. Clinical features in 11 patients. Parkinsonism & Related Disorders, 9, 175–178.10.1016/S1353-8020(02)00035-4
   PubMed Web of Science ®Google Scholar
• Shalev, A., Hermes, H., & Munitz, H. (1989). Mortality from neuroleptic malignant syndrome. The Journal of Clinical Psychiatry, 50, 18–25.
   PubMed Web of Science ®Google Scholar
• Sheu, Y., Furlan, A., Almusa, O., Papachristou, G., Bae, K. T. (2012). The revised Atlanta classification for acute pancreatitis: A CT imaging guide for radiologists. Emergency Radiology, 19, 237–243.10.1007/s10140-011-1001-4
   PubMedGoogle Scholar
• Singh, S., & Loke, Y. K. (2006). Statins and pancreatitis: A systematic review of observational studies and spontaneous case reports. Drug Safety, 29, 1123–1132.10.2165/00002018-200629120-00004
   PubMed Web of Science ®Google Scholar
• Singh, S., Nautiyal, A., & Dolan, J. G. (2004). Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? JOP, 5, 502–504.
   PubMedGoogle Scholar
• Trivedi, C. D., & Pitchumoni, C. S. (2005). Drug-induced pancreatitis: An update. Journal of Clinical Gastroenterology, 39, 709–716.10.1097/01.mcg.0000173929.60115.b4
   PubMed Web of Science ®Google Scholar
• Tysk, C., Al-Eryani, A. Y., & Shawabkeh, A. A. (2002). Acute pancreatitis induced by fluvastatin therapy. Journal of Clinical Gastroenterology, 35, 406–408.10.1097/00004836-200211000-00010
   PubMed Web of Science ®Google Scholar
• UK Guidelines for the Management of Acute Pancreatitis. (2005). Working party of the British society of gastroenterology, association of surgeons of Great Britain and Ireland, pancreatic society of Great Britain and Ireland, association of Upper GI surgeons of Great Britain and Ireland. Gut, 54, 1–9.
   PubMed Web of Science ®Google Scholar
• Velamoor, V. R. (1998). Neuroleptic malignant syndrome. Recognition, prevention and management. Drug Safety, 19, 73–82.10.2165/00002018-199819010-00006
   PubMed Web of Science ®Google Scholar
• Waldthaler, A., Schütte, K., & Malfertheiner, P. (2010). Causes and mechanisms in acute pancreatitis. Digestive Diseases, 28, 364–372.10.1159/000319416
   PubMed Web of Science ®Google Scholar
• Werth, B., Kuhn, M., Hartmann, K., & Reinhart, W. H. (1995). Medikamentos induzierte Pankreatitiden: Erfahrungen der Schweizerischen Arzneimittel-Nebenwirkungszentrale (SANZ) 1981–1993. Schweiz Med Wochenschr, 125, 731–734.
   PubMedGoogle Scholar
• Wu, Y. F., Kan, Y. S., & Yang, C. H. (2011). Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson’s disease - a case report. General Hospital Psychiatry, 33, 301.e7–301.e8.10.1016/j.genhosppsych.2010.11.013
   Google Scholar
• Zion, M. M., Goldberg, B., & Suzman, M. M. (1955). Corticotrophin and cortisone in the treatment of scleroderma. QJM, 24, 215–227.
   PubMed Web of Science ®Google Scholar